Cargando…
Microarray Analysis of Differentially-Expressed Genes Encoding CYP450 and Phase II Drug Metabolizing Enzymes in Psoriasis and Melanoma
Cytochrome P450 drug metabolizing enzymes are implicated in personalized medicine for two main reasons. First, inter-individual variability in CYP3A4 expression is a confounding factor during cancer treatment. Second, inhibition or induction of CYP3A4 can trigger adverse drug–drug interactions. Howe...
Autores principales: | Sumantran, Venil N., Mishra, Pratik, Bera, Rakesh, Sudhakar, Natarajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810080/ https://www.ncbi.nlm.nih.gov/pubmed/26901218 http://dx.doi.org/10.3390/pharmaceutics8010004 |
Ejemplares similares
-
Cancer, Inflammation, and Insights from Ayurveda
por: Sumantran, Venil N., et al.
Publicado: (2012) -
Can the vagus nerve serve as biomarker for vata dosha activity?
por: Sumantran, Venil N., et al.
Publicado: (2019) -
Epigallocatechin gallate & curcumin prevent transforming growth factor beta 1-induced epithelial to mesenchymal transition in ARPE-19 cells
por: Shanmuganathan, Sivasankar, et al.
Publicado: (2017) -
Function and regulation of a steroidogenic CYP450 enzyme in the mitochondrion of Toxoplasma gondii
por: Asady, Beejan, et al.
Publicado: (2023) -
A Global Comprehensive Study of the Distribution of Type I-E and Type I-E* CRISPR-Cas Systems in Klebsiella pneumoniae
por: Kannadasan, Anand Babu, et al.
Publicado: (2023)